Heart failure management includes the four pillars (quad therapy) in HFrEF and HFpEF, plus advances in heart transplantation and gene editing.
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading cause of liver disease worldwide, affecting one in three people.1,2 The inflammatory form of MASLD, namely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results